Indiana Daily Student

FDA authorizes Pfizer COVID-19 booster for children ages 12-15

The FDA announced children ages 12 to 15 are now eligible to receive the Pfizer-BioNTech COVID-19 booster shot in a press release Monday.

The FDA shortened the period of time those 12 and older need to wait between the initial Pfizer series vaccine and the Pfizer booster shot to five months, according to the press release. The original guidance was to wait six months, according to the press release.

This announcement comes as Indiana reported 12,020 daily cases on Dec. 30, the highest since the pandemic started, according to the IndyStar. 

Acting FDA Commissioner Janet Woodcock said in the press release as COVID-19 evolves the FDA has learned to adapt quickly using the best science available to protect Americans. 

The FDA also authorized the use of a third Pfizer series dose for immunocompromised children ages 5 to 11, according to the press release.

Like what you're reading?

Get more award-winning content delivered straight to your inbox. Sign up for our Daily Rundown.

Signup today!
Like what you're reading? Support independent, award-winning college journalism on this site. Donate here.

Powered by Solutions by The State News
All Content © 2022 Indiana Daily Student